A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants

Trial Identifier:	D7860C00003
Sponsor:	AstraZeneca
Start Date:	May 2024
Primary Completion Date:	December 2024
Study Completion Date:	December 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	Simplified Chinese (China) Translation
	English Version
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Glendale, CA, US, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.